雜志介紹

Toxicology And Applied Pharmacology雜志介紹

《Toxicology And Applied Pharmacology》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱毒理學(xué)與應(yīng)用藥理學(xué)，本刊主要出版、報(bào)道醫(yī)學(xué)-TOXICOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3.3，最新CiteScore 指數(shù)為6.8。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Drug repurposing of ilepcimide that ameliorates experimental autoimmune encephalomyelitis via restricting inflammatory response and oxidative stress

  Author: Xu, Zhaomin; Lu, Sisi; Liu, Xi; Tang, Lu; Liu, Zehui; Cui, Jiayan; Wang, Wanyan; Lu, Weiqiang; Huang, Jin

• Zinc finger protein 671 has a cancer-inhibiting function in colorectal carcinoma via the deactivation of Notch signaling

  Author: Wang, Yan; Chen, Fen-rong; Wei, Chong-cao; Sun, Lin-lang; Liu, Chen-yu; Yang, Long-bao; Guo, Xiao-yan

• Fibroblast growth factor 2 (FGF2) ameliorates the coagulation abnormalities in sepsis

  Author: Sun, Yuanyuan; Ye, Fanrong; Li, Ding; Yang, Hongjing; Xu, Tingting; Zhong, Xincun; Lu, Yilun; Zhou, Hongmin; Pan, Jingye

• Six first-line tyrosine kinase inhibitors reveal novel inhibition potential for the EGFR S768I mutation

  Author: Wang, Ying; Liu, Qian; Chu, Chunhong; Li, Lanxin; Wang, Zhenxing; Liu, Qiyu; Wu, Guangyao; Wei, Xiangkai; An, Lei; Ma, Jiguang

英文介紹

Toxicology And Applied Pharmacology雜志英文介紹

Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products.

Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of-the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged.

Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article.